StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 83.55 B
Share Price
USD 166.56
Avg Daily Volume
834,388
Change (1 day)
-0.50%
Change (1 year)
-20.05%
Change (YTD)
-4.43%
CSL Limited Revenue Year-on-Year (YoY) growth for the year ending June 30, 2024: -24.99%
CSL Limited Revenue Year-on-Year (YoY) growth is -24.99% for the year ending June 30, 2024. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period. Year-on-Year (YoY) growth is the change in a financial metric compared to the same period in the previous year, expressed as a percentage.
-
CSL Limited Revenue for the year ending June 30, 2023 was USD 19.59 B, a 35.36% change year over year.
-
CSL Limited Revenue for the year ending June 30, 2022 was USD 14.47 B, a 40.05% change year over year.
-
CSL Limited Revenue for the year ending June 30, 2021 was USD 10.33 B, a 9.84% change year over year.
-
CSL Limited Revenue for the year ending June 30, 2020 was USD 9.41 B, a 13.08% change year over year.
Competitors
Illumina, Inc.
USD 94.80
ILMN
-1.34
-1.40%
Revvity, Inc.
USD 90.72
RVTY
-2.54
-2.72%
Syngene International Limited
USD 7.73
SYNGENE.NS
-0.05
-0.65%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.43
002317.SZ
-0.02
-1.00%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.98
688321.SS
-0.02
-0.45%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Thermo Fisher Scientific Inc.
USD 404.94
TMO
-9.81
-2.37%
Boston Scientific Corporation
USD 103.78
BSX
+0.14
0.14%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
RELX Plc
USD 52.89
REL.L
-0.15
-0.29%
Key Data
| Date | Revenue Year-on-Year (YoY) growth | Gross Profit | Operating Income | EBIT |
|---|
Competitors
Illumina, Inc.
USD 94.80
ILMN
-1.34
-1.40%
Revvity, Inc.
USD 90.72
RVTY
-2.54
-2.72%
Syngene International Limited
USD 7.73
SYNGENE.NS
-0.05
-0.65%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.43
002317.SZ
-0.02
-1.00%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.98
688321.SS
-0.02
-0.45%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Thermo Fisher Scientific Inc.
USD 404.94
TMO
-9.81
-2.37%
Boston Scientific Corporation
USD 103.78
BSX
+0.14
0.14%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
RELX Plc
USD 52.89
REL.L
-0.15
-0.29%